Zver Tristan, Mouloungui Elodie, Berdin Aurélie, Roux Christophe, Amiot Clotilde
Centre Hospitalier Régional Universitaire Jean Minjoz, Service de Biologie et Médecine de la Reproduction - Cryobiologie, CECOS Franche-Comté Bourgogne, CIC-1431, 3 boulevard Fleming, F-25030, Besançon Cedex, France.
Université de Franche-Comté, 1 rue Goudimel, F-25030, Besançon Cedex, France.
J Ovarian Res. 2017 Jun 23;10(1):38. doi: 10.1186/s13048-017-0337-0.
Ovarian tissue cryopreservation is a technique for fertility preservation addressed to prepubertal girls or to patients for whom no ovarian stimulation is possible before initiation of gonadotoxic treatments. Autotransplantation of frozen-thawed ovarian tissue is the only available option for reuse but presents some limitations: ischemic tissue damages post-transplant and reintroduction of malignant cells in cases of cancer. It is therefore essential to qualify ovarian tissue before autograft on a functional and oncological point of view. Here, we aimed to isolate viable cells from human ovarian cortex in order to obtain an ovarian cell suspension analyzable by multicolor flow cytometry.
Ovarian tissue (fresh or frozen-thawed), from patients with polycystic ovarian syndrome (reference tissue) and from patients who underwent ovarian tissue cryopreservation, was used for dissociation with an automated device. Ovarian tissue-dissociated cells were analyzed by multicolor flow cytometry; the cell dissociation yield and viability were assessed. Two automated dissociation protocols (named laboratory and commercial protocols) were compared.
The effectiveness of the dissociation was not significantly different between reference ovarian tissue (1.58 × 10 ± 0.94 × 10 viable ovarian cells per 100 mg of ovarian cortex, n = 60) and tissue from ovarian tissue cryopreservation (1.70 × 10 ± 1.35 × 10 viable ovarian cells, n = 18). However, the viability was slightly different for fresh ovarian cortex compared to frozen-thawed ovarian cortex whether we used reference tissue (p = 0.022) or tissue from ovarian cryopreservation (p = 0.018). Comparing laboratory and commercial protocols, it appeared that cell yield was similar but cell viability was significantly improved when using the commercial protocol (81.3% ± 12.3% vs 23.9% ± 12.5%).
Both dissociation protocols allow us to isolate more than one million viable cells per 100 mg of ovarian cortex, but the viability is higher when using the commercial dissociation kit. Ovarian cortex dissociation is a promising tool for human ovarian cell qualification and for ovarian residual disease detection by multicolor flow cytometry.
卵巢组织冷冻保存是一种针对青春期前女孩或在开始性腺毒性治疗前无法进行卵巢刺激的患者的生育力保存技术。冻融卵巢组织的自体移植是唯一可行的再利用选择,但存在一些局限性:移植后缺血性组织损伤以及癌症病例中恶性细胞的重新引入。因此,从功能和肿瘤学角度对卵巢组织进行自体移植前的评估至关重要。在此,我们旨在从人卵巢皮质中分离活细胞,以获得可通过多色流式细胞术分析的卵巢细胞悬液。
使用来自多囊卵巢综合征患者(对照组织)和接受卵巢组织冷冻保存患者的卵巢组织(新鲜或冻融),通过自动化设备进行解离。对卵巢组织解离的细胞进行多色流式细胞术分析;评估细胞解离产量和活力。比较了两种自动化解离方案(分别称为实验室方案和商业方案)。
对照卵巢组织(每100mg卵巢皮质有1.58×10±0.94×10个活卵巢细胞,n = 60)和卵巢组织冷冻保存的组织(1.70×10±1.35×10个活卵巢细胞,n = 18)之间,解离效果无显著差异。然而,无论使用对照组织(p = 0.022)还是卵巢冷冻保存的组织(p = 0.018),新鲜卵巢皮质与冻融卵巢皮质的活力略有不同。比较实验室方案和商业方案时,似乎细胞产量相似,但使用商业方案时细胞活力显著提高(81.3%±12.3%对23.9%±12.5%)。
两种解离方案均能使我们从每100mg卵巢皮质中分离出超过一百万个活细胞,但使用商业解离试剂盒时活力更高。卵巢皮质解离是通过多色流式细胞术对人卵巢细胞进行评估和检测卵巢残留疾病的一种有前景的工具。